Megan Knight
Investor Relations Contact at ARENA PHARMACEUTICALS
Megan Knight active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ARENA PHARMACEUTICALS | Investor Relations Contact | - | - |
| LONGBOARD PHARMACEUTICALS, INC. | Investor Relations Contact | 2020-12-31 | - |
Career history of Megan Knight
Former positions of Megan Knight
| Companies | Position | Start | End |
|---|---|---|---|
| SENOMYX INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - |
Statistics
International
| United States | 4 |
Operational
| Investor Relations Contact | 3 |
| Public Communications Contact | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Non-Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| LONGBOARD PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA. | Consumer Non-Durables |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
- Stock Market
- Insiders
- Megan Knight
- Experience